Ardent Health vs Community Health Systems
ARDT and CYH side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ARDT and CYH compare
Ardent Health is the larger company, worth 8.8 times as much as Community Health Systems ($2.5B against $285M).
On earnings, Community Health Systems is cheaper: it trades at 7.8× trailing earnings, against 32.3× for Ardent Health.
Ardent Health grew revenue faster over the last twelve months (3.3% versus −7.8% for Community Health Systems).
Ardent Health keeps more of each dollar of sales as profit, with a net margin of 1.2% compared with 0.31% at Community Health Systems.
Community Health Systems scores higher on the StockData Score (8 against 7 for Ardent Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ARDT | CYH |
|---|---|---|
| Size and price | ||
| Market cap | $2.5B | $285M |
| Share price | $17.75 | $2.02 |
| Change, 1 year | 97.0% | −38.0% |
| Change, 5 years | – | −84.3% |
| Beta (5Y) | −0.20 | 1.50 |
| Employees | 25K | 57K |
| StockData Score | ||
| Total score | 7 | 8 (better) |
| Valuation score | 2 | 3 (better) |
| Growth score | 1 | 2 (better) |
| Performance score | 2 | 2 |
| Health score | 2 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 32.3× | 7.8× (better) |
| P/S | 0.4× | 0.0× (better) |
| P/B | 1.9× | – |
| EV/EBITDA | 8.8× | 5.8× (better) |
| PEG | – | 0.06 |
| FCF yield | – | −42.8% |
| Fair value | $18.37 | – |
| Margin of safety | 3.4% | – |
| Growth | ||
| Revenue growth (TTM) | 3.3% (better) | −7.8% |
| Revenue growth, 5Y average | – | 1.2% |
| Net income growth (TTM) | −69.3% (better) | −89.1% |
| EPS growth (TTM) | −69.6% (better) | −89.3% |
| EPS growth, 5Y average | – | −3.0% |
| Profitability | ||
| Gross margin | – | 85.5% |
| Operating margin | – | 10.9% |
| Net margin | 1.2% (better) | 0.31% |
| FCF margin | – | −1.0% |
| Return on equity | 6.0% | – |
| Return on invested capital | – | 7.5% |
| Financial health | ||
| Debt / equity | 0.82 | – |
| Net debt / EBITDA | 1.01 (better) | 5.54 |
| Current ratio | 2.10 (better) | 1.48 |
| Altman Z-score | 2.03 (better) | 1.00 |
| Piotroski F-score | 6 | 8 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 76.9% | 82.7% |
| Held by insiders | 2.7% | 9.0% |
| Insider net buying, 12 months | $186K (better) | −$118K |
| Short interest, % of float | 2.5% | 9.8% |
Go deeper
- ARDT stock overview
- ARDT income statement
- ARDT valuation and score
- CYH stock overview
- CYH income statement
- CYH valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.